| |
Biotechnology Value Fund Partners - Investor Profile
Primary Address: | Investor Information: | |
| 900 North Michigan Avenue | Total AUM ($MM): | Login to Access |
| Chicago, IL 60611 | Equity AUM ($MM): | Login to Access |
| Phone: Login to Access | Investment Style: | Login to Access |
| Fax: Login to Access | Orientation: | Login to Access |
| Investor Type: | Login to Access | |
Institutional Investor Background
Biotechnology Value Fund Partners LP (BVF Partners LP) is a private investment partnership founded in 1993 by President and Portfolio Manager Mark Lampert. Prior to founding BVF Partners,...
Login now or Register for a Free Account to access full Institutional Investor Background
Founders and Key Executives of Biotechnology Value Fund Partners: Mark N. Lampert
Entities related to Biotechnology Value Fund Partners: Biotechnology Value Fund II LP; Biotechnology Value Fund LP; BVF Inc; BVF Investments LLC; BVF Partners LP
*Denotes that the person or entity is no longer related to the firm.
Biotechnology Value Fund Partners's Top 10 Equity Holdings (as of 2011-06-30)
Biotechnology Value Fund Partners's Top 10 Equity Holdings (as of 2011-06-30)
| Value | ||||
| Company (Ticker) | ($MM) | Shares | Change | % Out |
| Rigel Pharmaceuticals Inc (RIGL) | 52.25 | 5,697,474 | 4,400,000 | 10.99 |
| Neurocrine Biosciences Inc (NBIX) | 28.17 | 3,499,765 | 0 | 6.38 |
| Ligand Pharmaceuticals Inc (LGND) | 25.22 | 2,110,482 | 259,487 | 10.75 |
| Infinity Pharmaceuticals Inc (INFI) | 21.25 | 2,572,908 | 0 | 9.84 |
| Oncothyreon Inc (ONTY) | 13.84 | 1,505,661 | 1,505,661 | 5.01 |
| Flamel Technologies Sa (FLML) | 10.71 | 2,002,527 | -155,407 | 8.36 |
| Pharmacyclics Inc (PCYC) | 10.30 | 986,700 | 365,800 | 1.65 |
| Palatin Technologies Inc (PTN) | 4.35 | 3,400,000 | 0 | 9.74 |
| Targacept Inc (TRGT) | 1.75 | 83,178 | -1,647,454 | 0.30 |
| Capstone Therapeutics Corp (CAPS) | 1.41 | 5,606,888 | 136,500 | 13.75 |
 |  | View Sample Report |
Articles Related to Biotechnology Value Fund Partners
Biotechnology Value Fund joins activist battle against Facet Biotech | ||
| Date: October 7th, 2009 | ||
| From this week’s Hedge Fund Solutions Catalyst Equity Research Report, we are highlighting the Biotechnology Value Fund’s investment in immunology... | ||
Login now or Register for a Free Account to access all Related Articles | ||
